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Summary.-Spleen cells from mice immunized against a methylcholanthrene
induced rhabdomyosarcoma inhibited tumour cell colony formation in vitro and
prevented tumour development in vivo in an adoptive transfer test. Treatment
of the immune spleen cells with anti-mouse immunoglobulin serum or passage
through a nylon wool column, both of which reduced the percentage of immuno-
globulin bearing cells in the population to less than 3-4%, did not alter their anti-
tumour effects. In contrast, treatment of the spleen cells with anti-BAO serum
abolished their anti-tumour effects both in vitro and in vivo. These results indicate
that T cells are the mediators oftumour immunity in this chemically induced tumour
system.
THE EFFECTOR cell(s) in anti-tumour im-
mune responses has not yet been clearly
identified. A previous study using Molo-
ney sarcoma virus (MSV) induced tumours
indicated that non-T cells were res-
ponsible for anti-tumour responses (Lamon
et al., 1972). However, two other reports
demonstrated that T cells were the
critical effector cells (Leclerc et al., 1973;
Gorczynski, 1974) while yet another study
implicated macrophages as effector cells
in a nonspecific killing mechanism in the
same tumour system (Owen and Seeger,
1973). It has been suggested that these
discrepancies might be due to the use of
different assays for anti-tumour immunity.
The studies by Lamon et al. (1972) used
the in vitro microcytotoxicity assay while
Leclerc et al. (1973) used an in vitro
chromium release technique and Gor-
czynski (1974) employed an in vivo
adoptive transfer method. Owen and
Seeger (1973) applied their isotopic tech-
nique (1251-UdR) which measures inhibi-
tion of tumour growth, thus approximat-
ing the classic colony inhibition method
of Hellstrom and Hellstrom (1970).
Since the MSV system is quite unique,
in that tumours commnonly regress after
a certain size is attained, it is possible
that more than one mechanism may be
involved in anti-tumour immunity in this
case. The purpose of the present study
was to examine the nature of the effector
cell(s) in a chemically induced tumour
system in which tumours never regress
spontaneously. Also, both an in vitro
(colony inhibition) and an in vivo (adoptive
transfer) assay were used to measure
anti-tumour responses.
MATERIALS AND METHODS
Mice.-DBA/2J female mice (Jackson
Laboratories, Bar Harbor, Maine) aged 2-4
months were used exclusively in these
studies.
Tumour system-.A methylcholanthrene
induced rhabdomyosarcoma (Jackson Labo-
ratories) was used herein. The growth
characteristics of this tumour and the
methods used for passaging it both in vitro
and in vivo have been described in detail
previously (Whitney, Levy and Smith,
1974). The tumour was initiated in DBA/2J
mice and has been maintained in this strain
for more than 2 years in our laboratory.
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with low doses of tumour cells (< 104), but
it does not grow in other strains tested
(CBA/J and AKR) even at a dose of 106
cells. This tumour is strongly immunogenic
in its strain oforigin since animals immunized
by surgical resection of growing transplanted
tumours uniformly rejected a challenge
inoculum of 105 tumour cells, which is 10
times the dose that produces tumours in
100% of untreated mice. Resected mice
were the immune animals used in these
experiments. The specificity of the immune
spleen cells for the immunizing tumour cells
was established by the observation that
these cells prevented the grow'th of the
tumour under study but not a mammary
adenocarcinoma or an unrelated methyl-
cholanthrene induced tumour (both of
DBA/2J origin) in the adoptive transfer
test.
Preparationt of antisera. Rabbit anti-
mouse brain associated 0 serum (anti-BAO)
was prepared as described by Barker,
Rheins and St Pierre (1973). The serum
was adsorbed with mouse liver homogenates
(6 ml anti-serum/1-5 ml packed liver tissue)
for 30 min at room temperature, inactivated
at 56°C for 30 min and sterilized by Millipore
filtration.
Treatment of appropriately immune cells
with this anti-BAO and complement did not
decrease the number of plaque-forming
cells to 2,4-dinitrophenyl coated sheep ery-
throcytes. Also, there was no detectable
killing of spleen cells from congenitally
athymic nude mice. Further, the propor-
tion of spleen cells binding labelled anti-Ig
increased after anti-BAO treatment. Finally,
the percentage of spleen cells killed by
anti-BAO (see Table I) was considerably
TABLE I.-Cytotoxic Effects of Anti-BAO
and Anti-Immunoglobulin Sera on Thy-
muns and Spleen Cells
Treatment*
None
Anti-BAO
Anti-Ig
% Non-viable cellst
Thymus Spleen
<3 <3
98±1 27±1
<3 47+ 1
* Cells were treated as described in the methods.
t Results are given as mean values + s.e. mean
where appropriate.
less than the upper limit of percentage
killed by conventional anti-6 in any mouse
strains. Thus, it was unlikely that B
lymphocytes were affected by this antiserum.
Autoradiographic studies with 1251-labelled
anti-BAO have also shown that it binds to
lymphocytes but not to macrophages.
Sheep anti-mouse immunoglobulin serum
(anti-Ig) was prepared by injecting purified
mouse Ig in complete Freund's adjuvant into
sheep. Sheep were immunized by 2 intra-
muscular injections of 10 mg of mouse Ig
in a 1 0 ml volume of5000 complete Freund's
adjuvant (Difco) 2 weeks apart. The anti-
serum was adsorbed -with DBA/2J thymus
cells (10 ml antiserum/108 cells) for 30 min
at room temperature, inactivated and filter
sterilized. Antiserum used for autoradio-
graphy was fractionated by repeated pre-
cipitation with 3300 saturated (NH4)2804,
after which it was dialysed exhaustively
against physiological saline.
Cytotoxic testing of antisera. Thymus or
spleen cells were first treated with NH4C1
(083% w/v) to remove erythrocytes. 107
cells were then incubated with 01 ml anti-
BAO or anti-Ig (1: 2 final dilution) plus
0 05 ml guinea-pig serum as the complement
(C') source and 0 05 ml phosphate buffered
saline (PBS) for 60 min at 37°C. At the
end of the incubation period, they were
washed once with PBS, diluted with trypan
blue and the dead cells enumerated.
In order to prepare cells for anti-tumour
immunity testing, 6 x 107 cells were incu-
bated with 0 4 ml anti-BAO or anti-Ig
plus 041 ml C' and 0 3 ml PBS for 60 min
at 37°C. They w"ere then -washed twice
with PBS before counting.
Autoradiography.-The percentage of Ig
bearing spleen lymphocytes was determined
using a direct autoradiographic procedure.
Fractionated sheep anti-mouse Ig was iodin-
ated by the chloramine-T procedure (Hunter
and Greenwood, 1962). The exact method
for preparation and development of slides
has been described elsewhere (Kelly et al.,
1974). The specific activity of the '251-anti-
mouse Ig was 1P5 ,uCi/tg protein. Slides
were left for 4 days at 4°C after dipping in
emulsion, and were then developed and
stained with Geimsa stain. Ig bearing cells
were easily detected as those heavily labelled
with grains (usually 20 or more grains were
visible on these cells). A total of 400
cells/test were counted.
N.ylon wool purification.-The percentage
of immunoglobulin bearing spleen cells was
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also reduced by passage through a nylon
wool column as has been described previously
(Julius, Simpson and Herzenberg, 1973).
Morphological examination of the effluent
population indicated no macrophages were
present, but the possibility that macrophage
precursors were still present cannot be
excluded.
Mitogen stimulation. Whole spleen cells
and separated fractions wvere cultured in
microtitre plates and were stimulated by
concanavalin A (con A) and E. coli endotoxin
(lipopolysaccharide, LPS) at 1 and 25
tg/ml respectively. The complete method
has been described in detail previously
(Whitney et al., 1974).
Tests for anti-tuntour inoniunity. The
colony inhibition technique of Hellstrom
and Hellstrom (1970) w%vas used as described
previously (XVhitney et al., 1974) to assess
anti-tumour immunity in vitro.
An adoptive transfer technique termed
neutralization, originally described by Winn
(1959) was used to measure anti-tumour
immunity in vivo. 104 tumour cells were
mixed with 3 x 106 spleen cells (whole or
fractionated) and were injected subcu-
taneously into normal recipients after a 1 h
incubation together in vitro at 37TC. Mice
were then observed for the development of
tumours as previously described (Whitney et
al., 1974).
Statistics. Neutralization data were
analysed using the Fisher Exact Test for
non-parametric statistics. All other results
are expressed as mean values + s.e. mean.
The statistical significance of differences in
mean values was determined by Student's
t test. Differences w%ere considered to be
significant if the probability that the ob-
served difference occurred by chance alone
was less than 50o (i.e., P < 0.05).
RESULTS
Several methods were used to demon-
strate the specificity of the antisera for
either T or B cells and the ability of the
nylon wool to reduce the proportion of B
cells. Cytotoxicity tests showed that
anti-BAO serum killed 98 10% and
27 ± 1% of thymus and spleen cells
respectively while anti-Ig serum had no
effect on thymus cells and killed 47 ± 100
of spleen cells (Table I). These results
agree well with the generally observed
cytotoxic effects of these antisera.
Autoradiography with 1251-labelled
anti-Ig demonstrated that 52 ] 3%0 of
spleen cells had surface immunoglobulin
(Table II), correlating well with the
47 ± 1% killed by anti-Ig serum. Since
less than 2% ofthymus cells were labelled
TABLE II. Frequency of Immrunoglobulin
Bearing Cells Detected by Autoradiography
% Labelledt
A
Treatment* Thymus Spleen
None <2 52+3
Anti-Ig N.T. 3±1
Nylon wool N.T. 442
* Cells were treated as (lescribe(l in the methods.
t The percentage of 1251-anti-Ig labelled cells
are given as mean values + s.e. mean where
appropriate (N.T. = not tested).
TABLE III. Effects of Various Treatments on Spleen Cell Responses to Sllitogens
3H-thymidine incorporation
(ct/min+s.e. mean)t
, ~~~~~A
None
2820± 1100
6020+ 303
5570+ 204
5730+ 539
2340+317
8190+1300
6000+ 195
2220+ 704
Con A
133000+14200
10000+688
161000+13800
137000 +5600
178000 2830
12500+447
151000+ 1070
134000+12800
LPS
79800+3590
64400 + 3470
16800+ 1600
43900+1920
62400±-8880
75800+ 2770
13400 + 1630
20400 + 2470
* Cells were treated as described in the methods.
t Results are expressed as mean ct/min s.e. mean of triplicate cultures (letermined after a 16 h
incubation with 3H-thymidine begun 48 h after mitogen additioni. Results of 2 typical experiments are
shown.
Experiment
no.
1
Treatment*
None
Anti-BAO
Anti-Ig
Nylon wvool
None
Anti-BAO
Anti-Ig
Nylon wool
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by this reagenit, it was quite specific for
B cells. Anti-Ig serum and the nylon
wool columns reduced the level of splenic
B cells to 3 { 1 and 4 A 2%.
Mitogen stimulations were used as
functional tests of T and B cell depletion.
The response to conA, a very specific T
cell mitogen (Anderson, Moller and Sjo-
berg, 1972), was always reduced by
90-97%0 (to approximately unstimulated
levels) by anti-BAO treatment (Table III)
while anti-Jg and nylon wool treatment
caused effects ranging from slight inhibi-
tion to moderate stimulation. Anti-BAO
treatment had little, if any, effect on
LPS stimulation which is reportedly a
B cell response (Greaves and Janossy,
1972). Anti-Ig and nylon wool treat-
ment never completely eliminated the
LPS response in our experiments, in
spite of their marked reduction of Ig
bearing cells. However, both treatments
significantly reduced the level of stimula-
tion in all cases by at least 40 and often
up to 80%. It should be noted that the
effect of the various treatments was
identical on both normal and tumour
immune spleen cells.
The neutralization technique provides
a sensitive in vivo assay for tumour
specific immunity. A large number of
experiments demonstrated that 100% of
mice inoculated with 104 tumour cells
developed tumours (Table IV). Normal
spleen cells had no protective effect when
inoculated with the tumour cells at a
ratio of 300: 1. Indeed, no protective
effect was observed with ratios up to
10,000 : 1. In contrast, only 15/69 (22%0)
mice receiving 104 tumour cells plus
spleen cells from immune mice at a
ratio of 300: 1 developed tumours. The
percentage of mice developing tumours
after receiving immune cells varied from
0 to 60% in individual experiments,
probably reflecting different levels of
immunity in different spleen cell donors.
In the series of neutralization experi-
ments performed to assess the effects of
anti-BAO and anti-Ig serum and nylon
wool on anti-tumour immunity, untreated
TABLE IV. Tumour Incidence in Mlice
Inoculated with Tumour (Cells Alone or
Mixed with Untreated Spleen Cells
Spleen
cell
source
None
Normal
Normal
Normal
Normal
Immune
Ratio
spleen:tumouir
300 : 1
600: 1
1000 :1
10000: 1
300: 1
Tumourt
frequency
51/51
73/73
6/6
5/5)
5/5
15/69
Statistical .
significance
NS
NS
NS
NS
P < 00(01
* Spleen cells were obtained from normal mice
or from mice immunizedl against the tumour.
t The number of mice developing tumours/total
number inoculated. M\:ice were inoculated with 10(4
tumour cells alone or in combination with the
variouis spleen cells at the indicated ratio after a
1 h incuibation together in vitro. AMice were
examine(d for tumour growth for 6 weeks. No
tumour appeared after 4 weeks in any experiment.
+ Statistical significance relative to the grouip of
mice receiving normal spleen cells at a 300: I
ratio was determine(d by the Fisher Exact Test.
TABLE V. Tumour Incidence in Mice
Inoculated with Different Populations of
Normal or Immune Spleen Cells
Spleen cell*
treatmenit
None
Anti-13A0
Anti-Ig
Xylon xvool
Tumour frequencyt
A
Normal
13/14
13/13
8/1)
5/5
Immune
0/27
24/25
0/14
0118
Stat,isticall
significance
P<0*0001
NS
P<0. 0001
P<0 0001
* Spleeii cells were treated as dlescribed in the
methods.
t The number of mice (leveloping tumours/total
number inoculated. Mice were inoculated( with
104 tumouir cells pluis 3 x 106> spleen cells (treated
as indicated) from normal or tumour immtune mice
after a 1 h itt vitro inicubation of the tumouir-spleen
cell mixture. Recipient mice were examined for
tumour growth for 6 weeks after treatment. Results
are the total of 2-4 separate experiments.
t Statistical significance of differences in tumour
frequency between recipients of immune and the
corresponding normal spleen cells treated the same
wNay wNas evaluated by the Fisher Exact Test.
immune spleen cells prevented tumour
development in all 27 mice tested (Table
V). Treatment of the immune cells with
anti-Ig serum, or by passage through
nylon wool, did not reduce the degree of
protection since none ofthe mice receiving
these cell populations developed tumours.
In contrast, anti-BAO treatment virtually
abolished the protective effect as 24/25
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TABLE VI.-Tumour Cell Colony Formation in the Presence ofDifferent
Populations of Normal or Immune Spleen Cells
Colonies/plate±s.e. meant
E"xperiment , Statisticalt
no. Treatment* Normal Immutne % Inhibition signiificance
1 None 96 8+4-6 91-3±5-6 6 NS
Aiiti-BAO 100±2* 2 102±36 - NS
Anti-Ig 96-0±2-0 17-3±9-0 82 P<0-001
2 None 93*9±2-9 75*8±33 5
79-3±2- 6
78 - 3±3 6
Anti-BAO 71-7±2 1 74-3±4-0
80-5±3-9
79-3±4-5
Anti-Ig 81-3±3-8 67-0±4-2
68- 8±1* 1
69' 7±3 * 1
3 None 77-0±1-8 65 012 7
66- 5±3-3
63-0±3-2
Anti-BAO 65-0±4 8 668±4 6
Aniti-Ig 620 0±t-4 4 48 0±2 1
63 3±3 8
47- 5;2- 6
19
16
17
18
15.
14
16
14
18
23
23
P<0. 01
P<0*02
P<0-01
NS
NS
NS
P<0 05
P<0 02
P<0.05
P<0 01
P<0-02
P<0 01
NS
P<005
NS
P<0-02
* Normal or immLune spleen cells were treated as described in the methods.
t Results are expressed as mean colonies'plate t s.e. mean of 3-12 replicate cultures. Normal cells
were pools of 3-4 individual normal mice an(l immune cells were either indlividual mice or pools of 2-3
mice.
I Statistical significance of (lifferences ini mean valu(es relative to similarly treated normal cells w%x(ere
evaluate(l by Student's t test.
mice developed tumours. Normal spleen
cells, either untreated or treated in any
of the 3 ways, also had no significant
protective effect since tumours grew in
all but 2 mice.
Colony inhibition experiments were
also carried out to determine anti-tumour
immunity in vitro. The results of several
representative experiments are given in
Table VI. Untreated immune spleen
cells significantly inhibited colony forma-
tion in 6/7 separate tests shown. Treat-
ment of the immune cells with anti-Ig
serum reduced their inhibitory effective-
ness relative to normal anti-Ig treated
cells in only 1/7 tests (immune animal
No. 2, Experiment 3). However, treat-
ment with anti-BAO serum completely
removed the anti-tumour reactivity of
immune cells in 5/5 tests shown as well
as in every other test performed with
anti-BAO in additional experiments not
presented. In Experiment 1 untreated
immune cells did not inhibit colony
formation, but after anti-Ig treatment
theywere veryeffective atinhibiting. Since
the total number of immune cells in
these tests was the same, the enhanced
inhibitory effect was probably due to
the relative increase in T cells. Also, in
Experiments 2 and 3 normal cells treated
with anti-Ig and anti-BAO significantly
reduced the colony number relative to
whole normal cells. Colony inhibition
tests were not carried out with nylon
wool treated cells since too few cells were
recovered from the columns to do both
assavs.
DISCUSSION
The present data clearly demonstrated
that anti-BAO serum abolished the anti-
tumour effects of spleen cells from tumour
immunized mice as assayed in vitro by
the colony inhibition method and in
vivo by an adoptive transfer technique.
In contrast, anti-Ig serum had no effect
on anti-tumour responises in vitro or in
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vivo. Passage of immune spleen cells
through a nylon wool column, which
eliminated macrophages and reduced the
percentage of Ig bearing cells to about
400, also did not alter their anti-tumour
effects in vivo. It can be concluded
from these observations that T and not
B lymphocytes are the anti-tumour effec-
tor cells in this chemically induced
rhabdomyosarcoma tumour system. Thus,
this syngeneic tumour system seems to
have the same rejection mechanism with
regard to the type of effector cell as does
the classic allograft reaction to H-2
antigens (Cerottini, Nordin and Brunner,
1970) and the tumour allograft reaction
(Freedman, Cerottini and Brunner, 1972).
It has recently been reported that T
lymphocytes could adoptively transfer
immunity to plasma cell tumours of
mice (Rouse, Rollinghoff and Warner,
1973). Therefore, it has now been shown
that anti-tumour immunity can be trans-
ferred in vivo only by T cells in chemically
and virally (Gorczynski, 1974) induced
" solid" tumour systems as well as in
a lymphoid tumour system which was,
however, grown in solid form. The in
vivo relevance of other mechanisms of
anti-tumour responses involving B cells
(Lamon et al., 1972) which have been
observed in vitro remains to be shown.
The present observations certainly do
not exclude the possibility that macro-
phages may also be important in the
effector mechanism. For example, T
lymphocytes adoptively transferred might
well recruit recipient macrophages to
effect cell killing. Indeed, a recent report
by Zarling and Tevethia (1973) showed
that tumour cell neutralization by im-
mune spleen cells was much less efficient
if recipients were pre-treated with silica,
a specific macrophage toxin.
Chia and Festenstein (1973) have
found that tumour bearing mice exten-
sively deprived of T cells by irradiation
and thymectomy have lymphoid cells
which are more effective at causing
tumour cell cytostasis in vitro than are
cells from non-deprived tumouir bearing
mice. A methyleholanthrene induced tu-
mour was used in these experiments.
Further, another more recent report by
Lamon et al. (1973) using the MSV
tumour system has shown that T cells
can have anti-tumour effects in the
microcytotoxicity assay, depending on
the point in tumour growth when they
are tested. They were found to be
active just before tumour development
and just after regression whereas the
non-T population was also active at
these times but retained its activity for
extended periods after regression. These
findings suggest that the major effector
mechanism may change during tumour
growth and that it may be different from
that of completely immunized, tumour-
free mice. However, Gorezynski (1974)
demonstrated the in vivo T cell require-
ment with cells taken from mice at a
time (28 days after MSV injection) when
T cell activity had waned according to
Lamon et al. (1973).
Because model tumour systems may
vary extensively in their interaction with
the immune system, and because it is
possible that the different methods of
assay may in fact measure the activity
of a variety of cell populations, it is
impossible to draw wide ranging conclu-
sions from limited experimental evidence.
It is clear that additional studies to
test effector cell function and identity
over the complete range of tumour
growth, and with a variety of tumour
systems, should be undertaken. It is
also clear that a variety of assays for
tumour immunity should be used simul-
taneously so that reliable conclusions
can be drawn regarding the significance
of observed results.
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